This site is intended for healthcare professionals only
LoginRegister
Aurobindo Pharma Gets 11 USFDA Observations at Eugia UnitUSFDA uncovers fresh faults at Aurobindo Pharma
CDSCO Orders Label Changes for Carbimazole, Doxycycline After PvPI Flags New ADR SignalsDrug Safety Alert: Indian Pharmacopoeia Commission Flags Adverse Reactions Linked To Teneligliptin
This Doctors Day Jb Pharma Launches JB NEXT, A Comprehensive Knowledge Based App For DoctorsThis Doctors' Day Jb Pharma Launches "JB NEXT", A Comprehensive Knowledge Based App For Doctors
Fire broke out in solvent reactor at Sahithi Pharma unit, 6 injuredFire broke out in solvent reactor at Sahithi Pharma unit, 6 injured
Lupin Signs Canada Licensing Pact with Spektus for Novel Antidepressant DeslaFlexLupin receives over Rs 205 crore from AbbVie for meeting key product development milestone
Shilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine PatchShilpa Biologicals gets marketing authorization permission for Adalimumab 40 mg/0.4mL injection in...
US FDA declines to approve Regenerons higher dose EyleaUS FDA declines to approve Regeneron's higher dose Eylea
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell CarcinomaMerck, Ridgeback Biotherapeutics withdraw COVID pill Molnupiravir application in EU
Sun Pharma, Philogen complete patient enrollment in Phase III trial for Soft Tissue SarcomaSun Pharma gets CDSCO Panel nod to study Lumateperone Capsules
Granules India inaugurates two advanced Centres of Excellence at IIT HyderabadGranules India warns of significant loss of revenue, profitability due to cyber attack
USFDA nod to JnJ Tremfya for Crohns diseaseCancer plaintiffs drill down on JnJ support for USD 8.9 billion talc deal
GSK concludes acquisition of BELLUS HealthGSK concludes acquisition of BELLUS Health
X